DEP's SALE OF COMPOZ TO MEDTECH LABS

DEP's SALE OF COMPOZ TO MEDTECH LABS continues the company's sell-off of OTC drug products acquired in the purchase of Jeffrey Martin. Medtech, an H&BA and OTC drug distributor, said in an Aug. 17 release that it "has acquired Compoz Night-time Sleep Aid from DEP Corporation." Medtech said that it plans to market Compoz "through drug, food and mass merchandisers in the U.S., Canada and Puerto Rico. After acquiring Jeffrey Martin in January, DEP sold Doan's Backache Pills to Ciba-Geigy for $34.4 mil in March ("The Pink Sheet" March 30, T&G-1). DEP also received an extra $600,000 for selling the international trademark rights for Doan's to Ciba-Geigy. The sale of Compoz was for about $1.3 mil., DEP said, adding that it recently signed a letter of intent to sell the OTC smoking deterrent Bantron. The firm expects to complete the deal next week and anticipates getting $1 mil. for Bantron. Remaining in the OTC drug area is Jeffrey Martin's appetite suppressant product, Ayds. With the sale of most of the OTC drug products, DEP still has Jeffrey Martin's health and beauty aids. That line includes Lavoris mouth wash, Topol Smoker's Toothpolish, Cuticura medicated soap and Porcelana fade cream. Cody, Wyoming-based Medtech's products include: New Skin, a liquid bandage, Nudit hair remover, Mosco foot care products and Tear Guard artifical tear.

Welcome to Pink Sheet

Create an account to read this article

More from Archive

Ocaliva: Still No Clarity On Why EU Court Opposed Revocation Of Approval

 

Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.

Final Chance To Have Your Say: Take Our Reader Survey This Week

 
• By 

This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.

Shape Our Content: Take The Reader Survey

 
• By 

We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.

Brazil Pilots Digital Drug Pack Inserts

 

A new pilot aims to take Brazil closer to ‘digital transformation.’

More from Pink Sheet

Opuni Appointed Acting CEO Of Ghana’s FDA As Darko Leaves To Lead African Medicines Agency

 

Kwabena Frimpong-Manso Opuni has been appointed as the new acting CEO of the Ghana Food and Drugs Authority, succeeding Delese Darko, who is now head of the Africa’s pan-continental medicines agency.

UK HRA Working On ‘Trusted’ Path Forward To Support Simplified Informed Consent

 
• By 

The Health Research Authority is working on a streamlined model for informed consent that maintains people’s trust.

EU Ups Ante On Stockpiling For Crises

 

The European Commission has published two new strategies on stockpiling that will improve the availability of critical medicines in times of crisis and reduce the EU’s dependance on suppliers outside the bloc.